ONCUSP THERAPEUTICS Trademark

Trademark Overview

On Friday, June 11, 2021, a trademark application was filed for ONCUSP THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ONCUSP THERAPEUTICS trademark a serial number of 90769580. The federal status of this trademark filing is REVIVED - AWAITING FURTHER ACTION as of Tuesday, October 8, 2024. This trademark is owned by OnCusp Therapeutics, Inc.. The ONCUSP THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer
oncusp therapeutics

General Information

Serial Number90769580
Word MarkONCUSP THERAPEUTICS
Filing DateFriday, June 11, 2021
Status616 - REVIVED - AWAITING FURTHER ACTION
Status DateTuesday, October 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 3, 2023

Trademark Statements

Description of MarkThe mark consists of a multi shaded ring with "OnCusp Therapeutics" in stylized font to the right of it.
Pseudo MarkON CUSP THERAPEUTICS
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesPharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 31, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOnCusp Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10013
Party NameOnCusp Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10024

Trademark Events

Event DateEvent Description
Wednesday, March 2, 2022ASSIGNED TO EXAMINER
Tuesday, June 15, 2021NEW APPLICATION ENTERED
Tuesday, August 31, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 1, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, July 28, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, March 3, 2022NON-FINAL ACTION WRITTEN
Thursday, March 3, 2022NON-FINAL ACTION E-MAILED
Thursday, March 3, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 22, 2022NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Wednesday, August 3, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 3, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 3, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 22, 2022REPORT UNRESPONSIVE AMENDMENT - COMPLETED
Monday, August 22, 2022NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Wednesday, September 21, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 4, 2022ASSIGNED TO LIE
Friday, November 4, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 4, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 29, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 3, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 3, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 10, 2023SOU EXTENSION 1 FILED
Wednesday, May 10, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, May 10, 2023SOU EXTENSION 1 GRANTED
Wednesday, February 28, 2024SOU EXTENSION 2 FILED
Friday, May 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 1, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, April 1, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, April 9, 2024PETITION TO REVIVE-GRANTED
Tuesday, April 9, 2024NOTICE OF REVIVAL - E-MAILED
Tuesday, April 9, 2024TEAS PETITION TO REVIVE RECEIVED
Tuesday, April 9, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, April 9, 2024TEAS PETITION TO REVIVE RECEIVED
Wednesday, June 12, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 13, 2024SOU EXTENSION 2 GRANTED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 8, 2024TEAS PETITION TO REVIVE RECEIVED
Tuesday, October 8, 2024NOTICE OF REVIVAL - E-MAILED
Tuesday, October 8, 2024PETITION TO REVIVE-GRANTED
Tuesday, October 8, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, September 30, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 30, 2024ABANDONMENT - NO USE STATEMENT FILED

Related Keywords

therapeutics oncusp research development pharmaceutical diseases cancer related fields biotechnology pharmaceuticals treatment